- Home
- PONY vs AXSM Comparison
PONY vs AXSM Comparison
Compare PONY & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PONY
- AXSM
- Stock Information
- Founded
- PONY 2016
- AXSM 2012
- Country
- PONY China
- AXSM United States
- Employees
- PONY N/A
- AXSM N/A
- Industry
- PONY
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- PONY
- AXSM Health Care
- Exchange
- PONY NYSE
- AXSM Nasdaq
- Market Cap
- PONY 5.1B
- AXSM 4.2B
- IPO Year
- PONY 2024
- AXSM 2015
- Fundamental
- Price
- PONY $13.44
- AXSM $102.46
- Analyst Decision
- PONY Strong Buy
- AXSM Strong Buy
- Analyst Count
- PONY 3
- AXSM 13
- Target Price
- PONY $19.20
- AXSM $130.69
- AVG Volume (30 Days)
- PONY 929.2K
- AXSM 1.1M
- Earning Date
- PONY 02-15-2025
- AXSM 02-18-2025
- Dividend Yield
- PONY N/A
- AXSM N/A
- EPS Growth
- PONY N/A
- AXSM N/A
- EPS
- PONY N/A
- AXSM N/A
- Revenue
- PONY $84,331,000.00
- AXSM $338,457,000.00
- Revenue This Year
- PONY $7.09
- AXSM $44.87
- Revenue Next Year
- PONY $6.98
- AXSM $67.93
- P/E Ratio
- PONY N/A
- AXSM N/A
- Revenue Growth
- PONY 16.56
- AXSM 51.47
- 52 Week Low
- PONY $11.90
- AXSM $64.11
- 52 Week High
- PONY $16.32
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- PONY N/A
- AXSM 63.95
- Support Level
- PONY N/A
- AXSM $91.81
- Resistance Level
- PONY N/A
- AXSM $105.64
- Average True Range (ATR)
- PONY 0.00
- AXSM 4.73
- MACD
- PONY 0.00
- AXSM 1.97
- Stochastic Oscillator
- PONY 0.00
- AXSM 87.98
About PONY PONY AI INC SPON ADS EACH REP 1 COM CL A
Pony AI Inc is an artificial intelligence technology company that principally engaged in the operation and development of autonomous vehicles. It operate fully driverless robotaxis through PonyPilot mobile app in Beijing, Shanghai, Guangzhou and Shenzhen. The company operate a fleet of nearly 250 robotaxis. The Group conducts its operation mainly in the People's Republic of China ("PRC") and the United States of America ("U.S.") through subsidiaries. Key revenue is generated from People's Republic of China.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.